New Jersey Health Foundation Commits $1 Million To Fund Next Round of Research Grants Program

Sep 09, 2015, 13:10 ET from New Jersey Health Foundation

NEW BRUNSWICK, N.J., Sept. 9, 2015 /PRNewswire-USNewswire/ -- New Jersey Health Foundation, a not-for-profit organization that funds research projects in the state of New Jersey, has committed $1 million for its next round of grant funding, announced James M. Golubieski, president.

Through its existing New Jersey Health Foundation Research Grants program, this latest allocation will fund awards of up to $35,000 each for early stage research projects that demonstrate exciting potential and may lead to larger future grants from other organizations to further advance the research.

Faculty and personnel at these organizations are able to apply:  Kessler Foundation, Princeton University, Rowan University, Rutgers University and Stevens Institute of Technology.  Applications will be accepted from September 15, 2015November 13, 2015. 

"There is an abundance of outstanding work being done by scientists and others throughout our state," explained George F. Heinrich, M.D., vice chair and CEO of New Jersey Health Foundation. "We are delighted to help advance these innovative research and technology projects by supporting potentially breakthrough science at these prestigious organizations."

In total, New Jersey Health Foundation has awarded more than $55 million to support early stage research in New Jersey.  A substantial number of these grant recipients have gone on to use their research results to attain significant grant awards from federal, state and private organizations. 

For more information, visit

About New Jersey Health Foundation
New Jersey Health Foundation ( is a not-for-profit corporation that supports biomedical research and health-related education programs in New Jersey through several grants programs and its affiliate, Foundation Venture Capital Group ( which makes private equity investments in life science start- up companies in New Jersey headed toward commercialization.


SOURCE New Jersey Health Foundation